利润表
TONIX PHARMACEUTICALS HOLDING CORP.
TNXP
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
13.11 | 10.10 | 7.77 | - | - | - | - | - | - | - | - | - | - | - |
|
营业成本
|
6.64 | 7.77 | 4.74 | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
6.47 | 2.34 | 3.03 | - | - | - | - | - | - | - | - | - | - | - |
|
营业费用
|
132.17 | 80.07 | 121.41 | 112.09 | 92.31 | 50.51 | 28.83 | 21.29 | 38.97 | 48.16 | 27.66 | 10.89 | 6.66 | 3.38 |
|
研发费用
|
44.49 | 39.97 | 86.66 | 81.88 | 68.84 | 36.16 | 18.19 | 13.34 | 28.53 | 35.50 | 18.62 | 4.65 | 2.58 | 1.16 |
|
销售、一般及行政费用
|
87.68 | 40.10 | 34.75 | 30.22 | 23.47 | 14.35 | 10.64 | 7.95 | 10.44 | 12.66 | 9.04 | 6.24 | 4.08 | 2.22 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-125.70 | -77.74 | -118.38 | -112.09 | -92.31 | -50.51 | -28.83 | -21.29 | -38.97 | -48.16 | -27.66 | -10.89 | -6.66 | -3.38 |
|
营业外收入
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
利息收入
|
4.15 | - | 1.72 | 1.87 | 0.03 | 0.05 | 0.21 | 0.17 | 0.13 | - | - | - | - | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - | - | 0.03 | - |
|
其他营业外收入/支出
|
-3.30 | -2.08 | - | - | - | - | - | - | - | - | - | - | - | - |
|
税前利润
|
- | - | - | - | - | - | - | -21.12 | -38.84 | -48.05 | -27.62 | - | - | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-124.02 | -130.04 | -116.66 | -110.22 | -92.29 | -50.46 | -28.62 | -21.12 | -38.84 | 0.00 | 0.00 | 0.00 | 0.00 | -3.47 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-123.78 | -74.32 | -114.09 | -110.84 | -92.26 | -50.48 | -28.80 | -21.22 | -38.76 | -48.16 | -27.66 | -10.89 | -6.66 | -3.38 |
|
基本每股收益
|
-14.57 | -176.60 | -6.85 | -3.27 | - | - | - | - | - | - | - | - | - | - |
|
稀释每股收益
|
-14.57 | -176.60 | -6.85 | -3.27 | - | - | - | - | - | - | - | - | - | - |
|
加权平均股数
|
8.51 | 0.74 | 17.04 | 35.74 | - | - | - | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
8.51 | 0.74 | 17.04 | 35.74 | - | - | - | - | - | - | - | - | - | - |
|
综合收益
|
-124.06 | -130.06 | -116.72 | -110.29 | -92.32 | -50.48 | -28.62 | -21.13 | -38.83 | -48.07 | -27.61 | -10.89 | - | - |